Really would love to hear more about your "extensive" research.
How is EYE compared to its competitors sales-wise? Valuations?
How much of the value is attributed to the MIGS business? How much of the value is from iAMD?
How do you view the growth opportunities in china for the closed eye segment?
How is EYE going to be affected By the proposed CMS changes?
surely your extensive research can enlighten me and answer at least some of my questions?
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-238
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.35M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.0¢ | $12.70K | 82.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 280687 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 25901 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |